Epidemiology of gestational diabetes mellitus in Latin America and the Caribbean: a scoping review
6 affiliations
- 1Research Unit of General Practice, Department of Public Health, University of Southern Denmark, Odense, Denmark
- 2Health Department, Universidad Iberoamericana, Mexico City, Mexico
- 3Research Unit of Gynecology and Obstetrics, Odense University Hospital, University of Southern Denmark, Odense, Denmark
- 4Department of Clinical Research, University of Southern Denmark, Odense, Denmark
- 5Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark
- 6Department of Perinatal Health, National Institute of Public Health, Cuernavaca, Mexico
Abstract
Gestational diabetes mellitus (GDM) is a major maternal health concern associated with adverse outcomes for mothers and their offspring. In Latin America and the Caribbean (LAC), its burden is heightened by socioeconomic inequalities, limited prenatal care, and high obesity rates, while evidence for other determinants remains fragmented and heterogeneous. This scoping review aimed to identify, describe, and categorize existing research on the prevalence, incidence, determinants, and risk factors of GDM in LAC. We conducted a scoping review following JBI guidance and PRISMA-ScR. Embase, MEDLINE/PubMed, Web of Science, SciELO, and LILACS were searched from inception to December 2025. Eligible studies included observational studies reporting GDM prevalence, incidence, diagnostic criteria, or risk factors in LAC. Two reviewers independently screened records and extracted data. Findings were synthesized descriptively. Fifty‑six studies from nine LAC countries were included, mainly from Brazil and Mexico. Studies were predominantly cross-sectional, cohort, and case-control designs conducted in hospital or prenatal care settings. Diagnostic approaches varied, with IADPSG (39.3%), WHO (25.0%), and ADA (16.1%) as the most frequently used criteria. GDM prevalence ranged from 3.0% to 61.0%, and incidence estimates varied substantially. The most frequently reported determinants and risk factors were advanced maternal age, overweight and obesity, family history of diabetes, previous GDM, prior macrosomia, and hypertension. Behavioral and social determinants were less frequently assessed. Variability in GDM prevalence across LAC highlights the need for standardized regional screening and prospective, population-based research. Reducing the regional GDM burden requires integrating clinical interventions targeting modifiable risk factors and improved continuity of care.
Related
- A machine learning-based predictive model for gestational diabetes mellitus based on first trimester clinical indicators
- Pregnancy Complicated by Citrin Deficiency and Gestational Diabetes Mellitus: Perioperative Metabolic Management and Postoperative Analgesic Challenges Following Caesarean Delivery
- Healthy lifestyles are associated with lower risk of gestational diabetes mellitus: a matched case–control study
- Preconceptional Risk Factors Associated With Gestational Diabetes Mellitus and Pregnancy Outcomes: A Case-Control Study
- Performance and Safety of a Continuous Glucose Monitoring System in Pregnant Women With Gestational Diabetes Mellitus: A Multicenter, Open-Label Trial
BibTeX
@article{granicharmenta2026epidemiology,
title = {{Epidemiology of gestational diabetes mellitus in Latin America and the Caribbean: a scoping review}},
author = {Adriana Granich-Armenta and Felipe Rangel-Osuna and Alejandra Cantoral and Mónica Ancira Moreno and Christina Anne Vinter and Héctor Lamadrid-Figueroa and Jesper Bo Nielsen and Jens Søndergaard and Fereshteh Baygi},
journal = {Global Health Action},
year = {2026},
month = nov,
doi = {10.1080/16549716.2026.2759388},
url = {https://doi.org/10.1080/16549716.2026.2759388},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Epidemiology of gestational diabetes mellitus in Latin America and the Caribbean: a scoping review
AU - Adriana Granich-Armenta
AU - Felipe Rangel-Osuna
AU - Alejandra Cantoral
AU - Mónica Ancira Moreno
AU - Christina Anne Vinter
AU - Héctor Lamadrid-Figueroa
AU - Jesper Bo Nielsen
AU - Jens Søndergaard
AU - Fereshteh Baygi
PY - 2026
DA - 2026/11/10
JO - Global Health Action
DO - 10.1080/16549716.2026.2759388
UR - https://doi.org/10.1080/16549716.2026.2759388
AB - Gestational diabetes mellitus (GDM) is a major maternal health concern associated with adverse outcomes for mothers and their offspring. In Latin America and the Caribbean (LAC), its burden is heightened by socioeconomic inequalities, limited prenatal care, and high obesity rates, while evidence for other determinants remains fragmented and heterogeneous. This scoping review aimed to identify, describe, and categorize existing research on the prevalence, incidence, determinants, and risk factors of GDM in LAC. We conducted a scoping review following JBI guidance and PRISMA-ScR. Embase, MEDLINE/PubMed, Web of Science, SciELO, and LILACS were searched from inception to December 2025. Eligible studies included observational studies reporting GDM prevalence, incidence, diagnostic criteria, or risk factors in LAC. Two reviewers independently screened records and extracted data. Findings were synthesized descriptively. Fifty‑six studies from nine LAC countries were included, mainly from Brazil and Mexico. Studies were predominantly cross-sectional, cohort, and case-control designs conducted in hospital or prenatal care settings. Diagnostic approaches varied, with IADPSG (39.3%), WHO (25.0%), and ADA (16.1%) as the most frequently used criteria. GDM prevalence ranged from 3.0% to 61.0%, and incidence estimates varied substantially. The most frequently reported determinants and risk factors were advanced maternal age, overweight and obesity, family history of diabetes, previous GDM, prior macrosomia, and hypertension. Behavioral and social determinants were less frequently assessed. Variability in GDM prevalence across LAC highlights the need for standardized regional screening and prospective, population-based research. Reducing the regional GDM burden requires integrating clinical interventions targeting modifiable risk factors and improved continuity of care.
SN - 1654-9716
SN - 1654-9880
ER -